SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950162-08-000530
Filing Date
2008-12-03
Accepted
2008-12-03 16:55:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SIGMA-TAU PHARMACEUTICALS/DOR BIOPHARMA - SCHEDULE 13G sigmataupharm13g_112608.htm SC 13G 239565
  Complete submission text file 0000950162-08-000530.txt   241702
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-39976 | Film No.: 081227964
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877
Business Address 800 SOUTH FREDERICK AVENUE SUITE 300 GAITHERSBURG MD 20877 1-800-447-0169
Sigma-Tau Pharmaceuticals, Inc. (Filed by) CIK: 0001385625 (see all company filings)

IRS No.: 953566292 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G